SCHEMBL16416625

SCHEMBL16416625

O=CCc1cc(F)cc(N(Cc2ccccc2)Cc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
CYP2C19 P33261 1/20 0.41
NR3C1 P04150 4/20 0.40
PTPN1 P18031 2/20 0.40
TSHR P16473 1/20 0.39
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
CETP P11597 1/20 0.36
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22658228 0.83 CRHBP (0.55) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL2881081 0.83 CYP2C19 (0.52) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL30910363 0.75 CRHBP (0.43) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL9809629 0.74 CRHBP (0.56) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL3629686 0.74 NR3C1 (0.46) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL8725184 0.73 CRHBP (0.51) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL16412580 0.73 CRHBP (0.55) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL16416561 0.73 CRHBP (0.42) CRHBPCRHR2CYP2C19NR3C1PTPN1
SCHEMBL2852852 0.73 TRPM8 (0.45) CRHBPCRHR2NR3C1PTPN1KMT2A
SCHEMBL2852847 0.73 TRPM8 (0.45) CRHBPCRHR2NR3C1PTPN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3024824-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF Agios Pharmaceuticals, Inc. (US) 2016-06-01 EP disclosed
WO-2015010297-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS, INC. (US) 2015-01-29 WO disclosed
WO-2015010626-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF AGIOS PHARMACEUTICALS, INC. (US) 2015-01-29 WO disclosed